Chromatography in Pharmacy & Pharmaceutical

One of the most characteristic features of the development in the methodology of medicinal and biomedical analysis is that HPLC came really the most important logical system for identification and quantification of medicines, either in their active pharmaceutical component or in their phrasings during the process of their discovery, development, and manufacturing.

Medicine development starts with the discovery of a patch with a remedial value. This can be done by high outturn webbing during which separations by fast or ultra-fast HPLC are performed. At the discovery stage, there can be also characterizing synthetic or natural products. Medicine metabolism and pharmacokinetics (DMPK) is the step where the seeker composites for medicine are tested for their metabolism and pharmacokinetics. The studies involve the use of LC-MS or LC-MS/MS. The thing in the discovery stage of medicine development is to discover a new, safe and active chemical reality (NCE) that will come as a drug for conditions. During the last decade parallel conflation of implicit lead composites, using combinatorial chemistry has been done. Due to its high perceptivity and selectivity, HPLC coupled with tandem mass spectrometry, HPLC-MS/ MS has come the predominant system in bioassays and pharmacokinetic and metabolic studies.

 

    Related Conference of Chromatography in Pharmacy & Pharmaceutical

    April 17-18, 2024

    14th International Conference on Chemistry Meeting

    Paris, France
    June 25-26, 2024

    13th World Congress on Chromatography

    Toronto, Canada
    August 22-23, 2024

    16th International Conference on Clinical Chemistry

    Berlin, Germany
    December 18-19, 2024

    4th International Conference on Petrochemistry and Natural Gas

    Amsterdam, Netherlands

    Chromatography in Pharmacy & Pharmaceutical Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in